Preparation and characterization of controlled release matrices based on novel seaweed interpolyelectrolyte complexes
Novel interpolyelectrolyte complexes (IPECs) between naturally sulfated polysaccharides of the seaweed Polysiphonia nigrescens (PN) and cationized agaroses (CAG) and Eudragit E (EE) were prepared using an organic solvent free process, characterized, and explored for controlled drug release. Tablets...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
2012
|
| Materias: | |
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 11956caa a22011417a 4500 | ||
|---|---|---|---|
| 001 | PAPER-9559 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518203929.0 | ||
| 008 | 190411s2012 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-84859612690 | |
| 024 | 7 | |2 cas |a agarose, 9012-36-6; eudragit, 24938-16-7, 51822-44-7, 9065-11-6; eudragit rs, 33434-24-1; ibuprofen, 15687-27-1, 31121-93-4, 527688-20-6, 79261-49-7; Delayed-Action Preparations; Electrolytes; Eudragit E PO; Excipients; Ibuprofen, 15687-27-1; Polymers; Polymethacrylic Acids; Polysaccharides; Sepharose, 9012-36-6; Tablets | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a IJPHD | ||
| 100 | 1 | |a Prado, H.J. | |
| 245 | 1 | 0 | |a Preparation and characterization of controlled release matrices based on novel seaweed interpolyelectrolyte complexes |
| 260 | |c 2012 | ||
| 270 | 1 | 0 | |m Matulewicz, M.C.; Departamento de Química Orgánica - CIHIDECAR-(CONICET-UBA), Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, C1428EGA Buenos Aires, Argentina; email: cristina@qo.fcen.uba.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a De La Torre, P.M., Enobakhare, Y., Torrado, G., Torrado, S., Release of amoxicillin from polyionic complexes of chitosan and poly(acrylic acid) study of polymer/polymer and polymer/drug interactions within the network structure (2003) Biomaterials, 24 (8), pp. 1499-1506. , DOI 10.1016/S0142-9612(02)00512-4, PII S0142961202005124 | ||
| 504 | |a Dulong, V., Lack, S., Le Cerf, D., Picton, L., Vannier, J.P., Muller, G., Hyaluronan-based hydrogels particles prepared by crosslinking with trisodium trimetaphosphate. Synthesis and characterization (2004) Carbohydr. Polym., 57, pp. 1-6 | ||
| 504 | |a Hennink, W.E., Van Nostrum, C.F., Novel crosslinking methods to design hydrogels (2002) Advanced Drug Delivery Reviews, 54 (1), pp. 13-36. , DOI 10.1016/S0169-409X(01)00240-X, PII S0169409X0100240X | ||
| 504 | |a Higgins, J.D., Gilmor, T.P., Martellucci, S.A., Bruce, R.D., Brittain, H.G., Ibuprofen (2001) Profiles of Drug Substances, Excipients and Related Methodology, 27, pp. 265-300. , PII S1075628001270086 | ||
| 504 | |a Huang, X., Brazel, C.S., On the importance and mechanisms of burst release in matrix-controlled drug delivery systems (2001) Journal of Controlled Release, 73 (2-3), pp. 121-136. , DOI 10.1016/S0168-3659(01)00248-6, PII S0168365901002486 | ||
| 504 | |a Lieberman, H.A., Lachman, L., (1980) Pharmaceutical Dosage Forms: Tablets, , Marcel Dekker, Inc. New York | ||
| 504 | |a Lowman, A.M., Complexing polymers in drug delivery (2000) Handbook of Pharmaceutical Controlled Release Technology, pp. 89-98. , D.L. Wise, Marcel Dekker New York | ||
| 504 | |a Meshali, M.M., Gabr, K.E., Effect of interpolymer complex formation of chitosan with pectin or acacia on the release behaviour of chlorpromazine HCl (1993) International Journal of Pharmaceutics, 89 (3), pp. 177-181. , DOI 10.1016/0378-5173(93)90241-7 | ||
| 504 | |a Moustafine, R.I., Kabanova, T.V., Kemenova, V.A., Van Den Mooter, G., Characteristics of interpolyelectrolyte complexes of Eudragit E100 with Eudragit L100 (2005) Journal of Controlled Release, 103 (1), pp. 191-198. , DOI 10.1016/j.jconrel.2004.11.031, PII S016836590400598X | ||
| 504 | |a Moustafine, R.I., Kemenova, V.A., Van Den Mooter, G., Characteristics of interpolyelectrolyte complexes of Eudragit E 100 with sodium alginate (2005) International Journal of Pharmaceutics, 294 (1-2), pp. 113-120. , DOI 10.1016/j.ijpharm.2005.01.029 | ||
| 504 | |a Moustafine, R.I., Zaharov, I.M., Kemenova, V.A., Physicochemical characterization and drug release properties of Eudragit® e PO/Eudragit® L 100-55 interpolyelectrolyte complexes (2006) Eur. J. Pharm. Biopharm., 63, pp. 26-36 | ||
| 504 | |a Moustafine, R.I., Margulis, E.B., Sibgatullina, L.F., Kemenova, V.A., Van Den Mooter, G., Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit® L100 and Eudragit® L100-55 as potential carriers for oral controlled drug delivery (2008) Eur. J. Pharm. Biopharm., 70, pp. 215-225 | ||
| 504 | |a Moustafine, R.I., Salachova, A.R., Frolova, E.S., Kemenova, V.A., Van Den Mooter, G., Interpolyelectrolyte complexes of Eudragit® e PO with sodium alginate as potential carriers for colonic drug delivery: Monitoring of structural transformation and composition changes during swellability and release evaluating (2009) Drug Dev. Ind. Pharm., 35, pp. 1439-1451 | ||
| 504 | |a Park, S.H., Chun, M.K., Choi, H.K., Preparation of an extended-release matrix tablet using chitosan/carbopol interpolymer complex (2008) Int. J. Pharm., 347, pp. 39-44 | ||
| 504 | |a Peppas, N.A., Analysis of Fickian and non-Fickian drug release from polymers (1985) Pharm. Acta Helv., 60, pp. 110-115 | ||
| 504 | |a Peppas, N.A., Bures, P., Leobandung, W., Ichikawa, H., Hydrogels in pharmaceutical formulations (2000) European Journal of Pharmaceutics and Biopharmaceutics, 50 (1), pp. 27-46. , DOI 10.1016/S0939-6411(00)00090-4, PII S0939641100000904 | ||
| 504 | |a Prado, H.J., Ciancia, M., Matulewicz, M.C., Agarans from the red seaweed Polysiphonia nigrescens (Rhodomelaceae, Ceramiales) (2008) Carbohydr. Res., 343, pp. 711-718 | ||
| 504 | |a Prado, H.J., Matulewicz, M.C., Bonelli, P., Cukierman, A.L., Basic butylated methacrylate copolymer/kappa-carrageenan interpolyelectrolyte complex: Preparation, characterization and drug release behaviour (2008) Eur. J. Pharm. Biopharm., 70, pp. 171-178 | ||
| 504 | |a Prado, H.J., Matulewicz, M.C., Bonelli, P.R., Cukierman, A.L., Preparation and characterization of a novel starch-based interpolyelectrolyte complex as matrix for controlled drug release (2009) Carbohydr. Res., 344, pp. 1325-1331 | ||
| 504 | |a Prado, H.J., Matulewicz, M.C., Bonelli, P.R., Cukierman, A.L., Studies on the cationization of agarose (2011) Carbohydr. Res., 346, pp. 311-321 | ||
| 504 | |a Satish, C., Satish, K., Shivakumar, H., Hydrogels as controlled drug delivery systems: Synthesis, crosslinking, water and drug transport mechanism (2006) Indian Journal of Pharmaceutical Sciences, 68 (2), pp. 133-140 | ||
| 504 | |a Siepmann, J., Peppas, N.A., Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC) (2001) Advanced Drug Delivery Reviews, 48 (2-3), pp. 139-157. , DOI 10.1016/S0169-409X(01)00112-0, PII S0169409X01001120 | ||
| 504 | |a Singh, S.K., Naini, V., Dosage forms: Non-parenterals (2007) Encyclopedia of Pharmaceutical Technology, pp. 988-1000. , J. Swarbrick, third ed. Informa Healthcare New York | ||
| 504 | |a Tapia, C., Costa, E., Moris, M., Sapag-Hagar, J., Valenzuela, F., Basualto, C., Study of the influence of the pH media dissolution, degree of polymerization, and degree of swelling of the polymers on the mechanism of release of diltiazem from matrices based on mixtures of chitosan/alginate (2002) Drug Development and Industrial Pharmacy, 28 (2), pp. 217-224. , DOI 10.1081/DDC-120002455 | ||
| 504 | |a Tapia, C., Escobar, Z., Costa, E., Sapag-Hagar, J., Valenzuela, F., Basualto, C., Gai, M.N., Yazdani-Pedram, M., Comparative studies on polyelectrolyte complexes and mixtures of chitosan-alginate and chitosan-carrageenan as prolonged diltiazem clorhydrate release systems (2004) European Journal of Pharmaceutics and Biopharmaceutics, 57 (1), pp. 65-75. , DOI 10.1016/S0939-6411(03)00153-X | ||
| 504 | |a Thünemann, A., Müller, M., Dautzenberg, H., Joanny, J., Löwen, H., Polyelectrolyte complexes (2004) Adv. Pol. Sci., 166, pp. 113-171. , M. Schmidt, Springer-Verlag Berlin | ||
| 504 | |a (2007) The United States Pharmacopeia 30/National Formulary 25, , USP 30/NF 25 United States Pharmacopeial Convention, Inc. USA | ||
| 520 | 3 | |a Novel interpolyelectrolyte complexes (IPECs) between naturally sulfated polysaccharides of the seaweed Polysiphonia nigrescens (PN) and cationized agaroses (CAG) and Eudragit E (EE) were prepared using an organic solvent free process, characterized, and explored for controlled drug release. Tablets containing model drug ibuprofen and IPECs were prepared by direct compression. Drug release in acid medium was low owing to the low solubility of ibuprofen in that condition and to the matrix action. Zero order drug release was determined in the buffer stage (pH = 6.8), with Fickian diffusion predominating over relaxation during the initial phases. Relaxation appears to increase along the release process and even overcomes diffusion for some systems. Drug release profiles could be controlled by varying the content of IPECs in the tablets. Also, the change in molecular weight and the degree of substitution of the components allowed altering the release profiles. © 2012 Elsevier B.V. |l eng | |
| 536 | |a Detalles de la financiación: Universidad de Buenos Aires, X137 | ||
| 536 | |a Detalles de la financiación: National Council for Scientific Research | ||
| 536 | |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas, PIP 112-200801-00234 | ||
| 536 | |a Detalles de la financiación: This work was supported by grants of the National Research Council of Argentina (CONICET, PIP 112-200801-00234 ) and the University of Buenos Aires (UBA, X137 ). M.C.M., P.R.B. and A.L.C. are research members of CONICET. H.J.P. received a doctoral fellowship from CONICET. Appendix A | ||
| 593 | |a Departamento de Química Orgánica - CIHIDECAR-(CONICET-UBA), Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, C1428EGA Buenos Aires, Argentina | ||
| 593 | |a PINMATE - Departamento de Industrias, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, C1428EGA Buenos Aires, Argentina | ||
| 593 | |a Cátedra de Farmacotecnia II, Departamento de Tecnología Farmacéutica, Universidad de Buenos Aires, Junín 956, C1113AAD Buenos Aires, Argentina | ||
| 593 | |a Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Av. Rivadavia 1917, C1033AAJ Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a CATIONIZED AGAROSE |
| 690 | 1 | 0 | |a CONTROLLED DRUG RELEASE |
| 690 | 1 | 0 | |a EUDRAGIT E |
| 690 | 1 | 0 | |a INTERPOLYELECTROLYTE COMPLEXES (IPECS) |
| 690 | 1 | 0 | |a POLYSIPHONIA NIGRESCENS |
| 690 | 1 | 0 | |a AGAROSE |
| 690 | 1 | 0 | |a EUDRAGIT |
| 690 | 1 | 0 | |a EUDRAGIT RS |
| 690 | 1 | 0 | |a IBUPROFEN |
| 690 | 1 | 0 | |a ORGANIC SOLVENT |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a DRUG RELEASE |
| 690 | 1 | 0 | |a MOLECULAR WEIGHT |
| 690 | 1 | 0 | |a NONHUMAN |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a SEAWEED |
| 690 | 1 | 0 | |a SOLUBILITY |
| 690 | 1 | 0 | |a TABLET |
| 690 | 1 | 0 | |a DELAYED-ACTION PREPARATIONS |
| 690 | 1 | 0 | |a DIFFUSION |
| 690 | 1 | 0 | |a DRUG COMPOUNDING |
| 690 | 1 | 0 | |a ELECTROLYTES |
| 690 | 1 | 0 | |a EXCIPIENTS |
| 690 | 1 | 0 | |a IBUPROFEN |
| 690 | 1 | 0 | |a MOLECULAR WEIGHT |
| 690 | 1 | 0 | |a POLYMERS |
| 690 | 1 | 0 | |a POLYMETHACRYLIC ACIDS |
| 690 | 1 | 0 | |a POLYSACCHARIDES |
| 690 | 1 | 0 | |a SEAWEED |
| 690 | 1 | 0 | |a SEPHAROSE |
| 690 | 1 | 0 | |a SOLUBILITY |
| 690 | 1 | 0 | |a TABLETS |
| 653 | 0 | 0 | |a eudragit |
| 700 | 1 | |a Matulewicz, M.C. | |
| 700 | 1 | |a Bonelli, P.R. | |
| 700 | 1 | |a Cukierman, A.L. | |
| 773 | 0 | |d 2012 |g v. 429 |h pp. 12-21 |k n. 1-2 |p Int. J. Pharm. |x 03785173 |w (AR-BaUEN)CENRE-5301 |t International Journal of Pharmaceutics | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859612690&doi=10.1016%2fj.ijpharm.2012.03.016&partnerID=40&md5=62d28ad64fffaeee63167061091451a9 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijpharm.2012.03.016 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_03785173_v429_n1-2_p12_Prado |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03785173_v429_n1-2_p12_Prado |y Registro en la Biblioteca Digital |
| 961 | |a paper_03785173_v429_n1-2_p12_Prado |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 70512 | ||